References
- Travis WD, Li CY, Bergstrahl EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 1988; 67(6), 345–368
- Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR. Hematologic manifestation of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. American Journal of Medicine 1991; 91: 612–624
- Webb TA, Li CY, Yam LT. Systemic Mast Cell Disease: A clinical and hematopathologic study of 26 cases. Cancer 1982; 49: 927–938
- Travis WD, Li CY, Bergstralh EJ. Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Archives of Pathology & Laboratory Medicine 1989; 113: 365–368
- Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988; 62: 965–972
- Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. British Journal of Haematology 1990; 76: 186–193
- Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Human Pathology 1985; 16: 808–814
- Hutchinson RM. Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders. Leukemia & Lymphoma 1992; 7(1–2)29–36
- Petrella T, Depret O, Amould L, Maynadie M, Guy H, Dalac S, Caillot D, Casasnovas O, Lombard JN. Systemic mast cell disease associated with hairy cell leukemia. Leukemia & Lymphoma 1997; 25: 593–595
- Parker RI. Hematologic aspects of mastocytosis II: Management of hematologic disorders in association with systemic mast cell disease. Journal of Investigative Dermatology 1991; 96: 52s, 54s
- Ho PJ, Gibson J, Vincent P, Joshua D. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation. Pathology 1993; 25: 297–304
- Brunning RD, McKenna RW. Atlas of Tumor Pathology. Tumors of the Bone Marrow. American Registry of Pathology, Washington, D. C. 1994; 419–437, Third series, Fasicle 9
- Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. American Journal of Clinical Pathology 1981; 75: 34–38
- Petit A, Pulik M, Gaulier A, Lionnet F, Mahe A, Sigal M. Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon-alfa therapy. Journal of American Academy of Dermatology 1995; 32: 850–853
- Pulik M, Lionnet F, Petit A, Genet P, Gaulier A. Long-term response to interferon-alpha in patient with systemic mastocytosis and chronic myelomonocytic leukemia (letter). American Journal of Hematology 1994; 47: 66
- Ronnov-Jessen D, Neilsen PL, Horn T. Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marrow Transplantation 1991; 8: 413–415
- Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia: Report of a case and review of the literature. Mayo Clinic Proceedings 1986; 61: 957–966